Back to Authors

Hindorff, Lucia A.

https://orcid.org/0000-0002-4414-3236

Mayo Clinic

National Human Genome Research Institute

Citations 3

Abstract P252: Generalization and Fine Mapping of PR Interval Loci in Hispanics: The Population Architecture Using Genomics and Epidemiology (PAGE) Study
Seyerle, Amanda A. , Wassel, Christina L. , Carty, Cara L. , Fornage, Myriam , Duggan, David , Gong, Jian , Heckbert, Susan R. , Hindorff, Lucia A. , Jeff, Janina M., Okin, Peter M., Shohet, Ralph V. , Sotoodehnia, Nona, Wu, Chunyuan , Bielinski, Suzette J. , Buyske, Steven , Carnethon, Mercedes R. , Crawford, Dana C. , Lloyd‐Jones, Donald M. , Pérez, Marco , Psaty, Bruce M. , Rotter, Jerome I. , Shah, Sanjiv J , Soliman, Elsayed Z. , Kooperberg, Charles , Avery, Christy L.

Circulation | July 3, 2021 | Volume: 129 | Issue: suppl_1 | Pages: No page available

10.1161/circ.129.suppl_1.p252 Get It

PR interval (PR) prolongation is a predictor of atrial fibrillation, a common cardiac arrhythmia, and is an established risk factor for pacemaker implantation, heart failure, stroke, and all-cause mortality. Previous genome-wide association studies in European (EU) and African (AA) descent populations have identified multiple loci associated with PR. However, it is unclear whether these loci are relevant in other racial groups, including Hispanic/Latinos (HL). Extending studies to include admixed populations such as HL also provides the potential to narrow regions associated with PR and identify population specific variants. Therefore, we evaluated 1,135 SNPs from four previously identified PR loci ( SCN5A, SCN10A, CAV1-CAV2, and TBX5-TBX3 ), fine-mapped on the Illumina Metabochip for association with PR. Associations were examined using linear regression assuming an additive genetic model and adjusting for global ancestry and clinical covariates (age, sex, RR interval, body mass index, height, systolic blood pressure) in 11,800 HL participants from participating studies of the Population Architecture using Genomics and Epidemiology (PAGE) consortia. Three of the four loci ( SCN5A, SCN10A, and CAV1-CAV2 ) generalized to HL populations ( P <7.1E-4 based on the number of SNPs correlated at r 2 >0.2 with EU-identified index SNPs). At each of these loci, we identified SNPs with stronger evidence of association with PR than the EU-identified index SNP when examined in the HL population ( SCN5A : rs7374540; SCN10A : rs6801957; CAV-CAV2 : rs717957). Conditional analyses also identified two additional independent SNPs at each of the three generalized loci ( SCN5A : rs3796387, rs9861242; SCN10A : rs10428132, rs7433723; CAV1-CAV2 : rs3801995, rs3807994), representing potential secondary signals. Furthermore, linkage disequilibrium (LD) patterns in Hispanics enabled the narrowing of the regions flanking the EU-identified index SNPs. For example, at the CAV1-CAV2 locus, HL LD patterns indicated that seven SNPs were in LD with rs3807989, the EU-identified index SNP, compared to 17 SNPs that were in LD with rs3807989 when applying EU LD patterns, reducing the size of the region by 71 kilobases. Finally, we examined evidence for population specific signals outside of the specific regions identified in EU populations which were associated with PR in Hispanics by focusing on SNPs uncorrelated with the EU index signals. At all four loci, multiple SNPs had evidence of association independent of the signals examined based on EU results. In conclusion, the same genetic loci that influence PR in European descent populations are also important in Hispanic populations, although we detected evidence for population specific SNPs. These results emphasize the importance of examining genetic associations in diverse populations in order to narrow the genomic interval for future functional interrogation.
CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record
Shirts, Brian H. , Salama, Joseph S , Aronson, Samuel , Gray, Stacy W. , Hindorff, Lucia A. , Jarvik, Gail P. , Tarczy‐Hornoch, Peter , Freimuth, Robert R. , Grundmeier, Robert W. , Hartzler, Andrea L. , Li, Rongling, Peissig, Peggy , Peterson, Josh F. , Rasmussen, Luke V. , Starren, Justin , Overby, Casey Lynnette, Taylor, Casey Overby , Chute, Christopher G. , Chung, Wendy K. , Plon, Sharon E. , Stoffel, Elena M. , Van Allen, Eliezer M , Weck, Karen E. , Williams, Marc S , Jarvik, Gail P , Rasmussen, Luke V , Freimuth, Robert R , Peterson, Josh F , Gray, Stacy W

Journal of the American Medical Informatics Association | July 4, 2015 | Volume: 22 | Issue: 6 | Pages: 1231-1242

10.1093/jamia/ocv065 Get It

Abstract Objective Clinicians’ ability to use and interpret genetic information depends upon how those data are displayed in electronic health records (EHRs). There is a critical need to develop systems to effectively display genetic information in EHRs and augment clinical decision support (CDS). Materials and Methods The National Institutes of Health (NIH)-sponsored Clinical Sequencing Exploratory Research and Electronic Medical Records & Genomics EHR Working Groups conducted a multiphase, iterative process involving working group discussions and 2 surveys in order to determine how genetic and genomic information are currently displayed in EHRs, envision optimal uses for different types of genetic or genomic information, and prioritize areas for EHR improvement. Results There is substantial heterogeneity in how genetic information enters and is documented in EHR systems. Most institutions indicated that genetic information was displayed in multiple locations in their EHRs. Among surveyed institutions, genetic information enters the EHR through multiple laboratory sources and through clinician notes. For laboratory-based data, the source laboratory was the main determinant of the location of genetic information in the EHR. The highest priority recommendation was to address the need to implement CDS mechanisms and content for decision support for medically actionable genetic information. Conclusion Heterogeneity of genetic information flow and importance of source laboratory, rather than clinical content, as a determinant of information representation are major barriers to using genetic information optimally in patient care. Greater effort to develop interoperable systems to receive and consistently display genetic and/or genomic information and alert clinicians to genomic-dependent improvements to clinical care is recommended.
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia
Kocarnik, Jonathan , Lindor, Noralane M. , Chang‐Claude, Jenny , Caberto, Christian, Love, Shelly-Ann, Slattery, Martha L. , Hindorff, Lucia A. , Park, Sungshim Lani, Schumacher, Fredrick R. , Hoffmeister, Michael , Duggan, David , Hou, Lifang , Carlson, Chris , Carty, Cara L. , Mann, Sue, Giovannucci, Edward L. , Fuchs, Charles S. , Jenkins, Mark A. , Haile, Robert W. , Conti, David V. , Potter, John D. , Caan, Bette J. , Hayes, Richard B. , Berndt, Sonja I. , Küry, Sébastien , Bezieau, Stéphane , Ambite, José Luis , Kumaraguruparan, Gowri, Richardson, Danielle , Goodloe, Robert, Dilks, Holli H., Baker, Paxton, Zanke, Brent W., Lemire, Mathieu , Gallinger, Steven , Jiao, Shuo , Harrison, Tabitha A. , Seminara, Daniela, Haiman, Christopher A. , Hutter, Carolyn M., Crawford, Dana C. , Heiss, Gerardo , Brenner, Hermann , Bush, William S. , Casey, Graham , Peters, Ulrike , Cheng, Iona C. , Dumitrescu, Logan , Avery, Christy L. , Chan, Andrew T. , Baron, John A. , Kraft, Peter , Butler, Anne Marie E. , Monroe, Kristine R. , Lin, Yi , Ma, Jing , Newcomb, Polly A. , Hopper, John L. , Campbell, Peter T. , Schoen, Robert E. , Chanock, Stephen Jacob , Hsu, Li , Kooperberg, Charles , Wilkens, Lynne R. , White, Emily E. , Hudson, Thomas J , Marchand, Loı̈c Le , Hoffmeister, Michael , Jenkins, Mark A , Haile, Robert W , Harrison, Tabitha A , Potter, John D , Kury, Sebastien , Brenner, Hermann , Hayes, Richard B , Bézieau, Stéphane , Conti, David V , Hou, Lifang , Caan, Bette J , Bush, William S

Gut | August 10, 2013 | Volume: 63 | Issue: 5 | Pages: 800-807

10.1136/gutjnl-2013-305189 Get It

Objective Genome-wide association studies have identified a large number of single nucleotide polymorphisms (SNPs) associated with a wide array of cancer sites. Several of these variants demonstrate associations with multiple cancers, suggesting pleiotropic effects and shared biological mechanisms across some cancers. We hypothesised that SNPs previously associated with other cancers may additionally be associated with colorectal cancer. In a large-scale study, we examined 171 SNPs previously associated with 18 different cancers for their associations with colorectal cancer. Design We examined 13 338 colorectal cancer cases and 40 967 controls from three consortia: Population Architecture using Genomics and Epidemiology (PAGE), Genetic Epidemiology of Colorectal Cancer (GECCO), and the Colon Cancer Family Registry (CCFR). Study-specific logistic regression results, adjusted for age, sex, principal components of genetic ancestry, and/or study specific factors (as relevant) were combined using fixed-effect meta-analyses to evaluate the association between each SNP and colorectal cancer risk. A Bonferroni-corrected p value of 2.92×10 −4 was used to determine statistical significance of the associations. Results Two correlated SNPs—rs10090154 and rs4242382—in Region 1 of chromosome 8q24, a prostate cancer susceptibility region, demonstrated statistically significant associations with colorectal cancer risk. The most significant association was observed with rs4242382 (meta-analysis OR=1.12; 95% CI 1.07 to 1.18; p=1.74×10 −5 ), which also demonstrated similar associations across racial/ethnic populations and anatomical sub-sites. Conclusions This is the first study to clearly demonstrate Region 1 of chromosome 8q24 as a susceptibility locus for colorectal cancer; thus, adding colorectal cancer to the list of cancer sites linked to this particular multicancer risk region at 8q24.